Claudio Bonifati

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 9

Top Topics

Cross Sectional

Ejection Fraction

Juvenile Idiopathic Arthritis

Top Venues

Dermatologic therapy

The Journal of dermatological treatment

Expert opinion on biological therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Orsini Diego, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio Giovanni Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro Marco Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study). The Journal of dermatological treatment 35 (1) (2024)
Orsini Diego, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio Giovanni Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro Marco Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study). The Journal of dermatological treatment 35 (1) (2024)
Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, Mauro Bavetta, Clara De Simone, Dario Graceffa, Claudio Bonifati, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Ketty Peris, Luca Bianchi
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study. Dermatologic therapy 35 (6) (2022)
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Diotallevi Federico, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Giovanni Richetta, Nevena Skroza, Laura Atzori, Maria-Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza, Luca Bianchi
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year. Expert opinion on biological therapy (2022)
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Giovanni Richetta, Lidia Sacchelli, Luca Bianchi, Ketty Peris
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert opinion on biological therapy 21 (9) (2021)
Dario Graceffa, Claudio Bonifati, Alessia Pacifico, Aldo Morrone
When the old works better than the new: A case of severe nail psoriasis successfully treated with acitretin after failure of two biologic regimens. Dermatologic therapy 33 (4) (2020)
Claudio Bonifati, Aldo Morrone, Antonio Cristaudo, Dario Graceffa
Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience. Dermatologic therapy 34 (1) (2020)
Giovanni Damiani, Alessia Pacifico, Filomena Russo, Paolo Daniele Maria Pigatto, Nicola Luigi Bragazzi, Claudio Bonifati, Aldo Morrone, Abdulla Watad, Mohammad Adawi
Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study. Journal of clinical medicine 8 (6) (2019)
Viviana Lora, Dario Graceffa, Catia De Felice, Aldo Morrone, Claudio Bonifati
Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection. Dermatologic therapy 32 (3) (2019)
Claudio Bonifati, Fulvia Elia, Dario Graceffa, Fabrizio Ceralli, Elisa Maiani, Carlo De Mutiis, Francesco M Solivetti
Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients after One Year of Continuous Therapy with Anti-TNF Drugs. ISRN dermatology 2014 (2014)